Home
>
National Drug Code (NDC)
>
GABAPENTIN
GABAPENTIN - 76282-321-01 - (GABAPENTIN)
Drug Information of GABAPENTIN
| Product NDC: | 76282-321 |
| Proprietary Name: | GABAPENTIN |
| Non Proprietary Name: | GABAPENTIN |
| Active Ingredient(s): | 100 mg/1 & nbsp; GABAPENTIN |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of GABAPENTIN
| Product NDC: | 76282-321 |
| Labeler Name: | Exelan Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090705 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100426 |
Package Information of GABAPENTIN
| Package NDC: | 76282-321-01 |
| Package Description: | 100 CAPSULE in 1 BOTTLE (76282-321-01) |
NDC Information of GABAPENTIN
| NDC Code | 76282-321-01 |
| Proprietary Name | GABAPENTIN |
| Package Description | 100 CAPSULE in 1 BOTTLE (76282-321-01) |
| Product NDC | 76282-321 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | GABAPENTIN |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20100426 |
| Marketing Category Name | ANDA |
| Labeler Name | Exelan Pharmaceuticals, Inc. |
| Substance Name | GABAPENTIN |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
